Pure Global
NCT06412133

Conversations in Light and Shadow: Assessing Phototherapy's Impact on Breast Cancer Patients

Conversations in Light and Shadow: Assessing Phototherapy's Impact on Breast Cancer Patients: Study Protocol for a Multicenter, Randomized Controlled Trial
Yun-Chen Chang·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Breast Cancer,Breast Cancer Female,Randomized Controlled Trial
Drug/Device/Intervention
photography
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Yun-Chen Chang
Funder
China Medical University, China
Location
Taichung City,Taichung City, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Sep 17, 2024
End date
Jul 01, 2025
Enrollment
57 participants
Primary outcome

Depression Anxiety Stress Scale (DASS-21),body image scale (BIS)

Summary

This study examines the impact of phototherapy intervention on anxiety, stress, and body
 image among breast cancer patients. Participants engaged in a five-week, one-on-one session
 series, utilizing a pre-post-test design with parallel groups. Quantitative data were
 collected using the Depression Anxiety Stress Scales (DASS-21) and the Body Image Scale. In
 addition to quantitative measures, in-depth individual interviews were conducted to gather
 qualitative data. The combined data were then analysed to assess the effectiveness of the
 intervention.

ICD-10 classifications
Special screening examination for neoplasm of breastPersonal history of malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm of breastFollow-up care involving plastic surgery of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06412133
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06412133 through Pure Global AI's free database. This phase not specified trial is sponsored by Yun-Chen Chang and is currently Not yet recruiting. The study focuses on Breast Cancer,Breast Cancer Female,Randomized Controlled Trial. Target enrollment is 57 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.